SPOTLIGHT: Judge says Wyeth's not liable


A federal appeals court ruled in favor of Wyeth in the case of a Little Rock woman who developed breast cancer while taking the company's hormone replacement therapy, Premarin and Prempro. The court upheld a jury's verdict that Wyeth wasn't liable. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.